Calcium levofolinate clinical trials
Calcium levofolinate is named as an intervention in 3 current clinical trials in our China and Italy registers. 2 are recruiting patients now. All registered phases are Phase 3. The sponsor with the most trials is Sichuan Baili Pharmaceutical Co., Ltd (2). The most-studied condition is Biliary Tract Cancer. The EU clinical trials register (CTIS) separately lists 2 authorised or ongoing trials.
How Calcium levofolinate works
All drug targets →- Colorectal cancerPhase 3
- Gastric cancerPhase 3
- Malignant colon neoplasmPhase 3
- Metastatic colorectal cancerPhase 3
- Colorectal carcinomaPhase 2
- Esophageal squamous cell carcinomaPhase 2
- Hepatocellular carcinomaPhase 2
- Malignant pancreatic neoplasmPhase 2
- Pancreatic neoplasmPhase 2
- Pancreatic ductal adenocarcinomaPhase 1
Mechanisms and diseases from ChEMBL via the Open Targets Platform (release 26.09), ChEMBL record CHEMBL1908361, CC BY-SA 3.0. The Guide to Pharmacology has no record of this medicine, so its targets rest on ChEMBL alone. Trial phases are not approvals: approved uses are shown from the regulators' own records where we hold them.
Patient leaflets for Calcium levofolinate
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Reference identifiers for Calcium levofolinate
- ATC code
- V03AF04
- ChEMBL
- CHEMBL1908361
- PubChem CID
- 137183587
- CAS number
- 80433-71-2
- FDA UNII
- 778XL6VBS8
- Wikidata
- Q11349901
Codes that identify this medicine in other databases, from Wikidata (CC0), matched by its ChEMBL ID. The ATC code is the WHO classification of what the medicine is used for.
Trials by status
Trials by phase
Clinical trials of Calcium levofolinate
3 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01)
NCT07582315 · ClinicalTrials.gov ↗ · Biliary Tract Cancer
|
Phase 3 | Recruiting | Sichuan Baili Pharmaceutical Co., Ltd | China |
|
A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure
NCT07606599 · ClinicalTrials.gov ↗ · Biliary Tract Cancer
|
Phase 3 | Recruiting | Sichuan Baili Pharmaceutical Co., Ltd | China |
|
Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB
NCT04776655 · ClinicalTrials.gov ↗ · Colorectal Cancer, Metastatic Colorectal Cancer, RAS Mutation
|
Phase 3 | Active, closed | Azienda USL Reggio Emilia - IRCCS | Italy |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Calcium levofolinate in the EU trials register (CTIS)
2 trialsAuthorised or ongoing trials in the EU Clinical Trials Information System that list a product containing Calcium levofolinate. Many trials are registered in both CTIS and ClinicalTrials.gov, so these are shown separately rather than added to the count above. Trials with a site in Ireland are listed first.
| Study | Phase | Status | Sponsor | Countries |
|---|---|---|---|---|
|
PACHA-02_Postoperative hepatic arterial chemotherapy after resection of colorectal liver metastases in patients at high risk of recurrence
2025-523913-27-00 · CTIS ↗ · Neoplasms
|
Phase 3 | Authorised | Unicancer | France |
|
NACRE 2_Randomized phase III study evaluating two treatment strategies for locally advanced rectal cancer in patients ≥75 years old
2025-521619-37-00 · CTIS ↗ · Neoplasms
|
Phase 3 | Authorised | Unicancer | France |
Conditions studied with Calcium levofolinate
4 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Sichuan Baili Pharmaceutical Co., Ltd | 2 |
| Azienda USL Reggio Emilia - IRCCS | 1 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 2 | 2 |
| Clinical trials in Italy | 1 | 0 |
| EU register (CTIS) | 2 | — |
A trial with sites in more than one country appears in each of those registers. CTIS does not publish a recruiting flag; its trials may also appear in the registers above.
Related compounds
Questions about Calcium levofolinate trials
How many clinical trials are testing Calcium levofolinate?
3 current trials in our China and Italy registers name Calcium levofolinate as a drug or biological intervention, as of the registry sync on 9 November 2026. Completed and withdrawn studies are not counted.
Are Calcium levofolinate trials recruiting patients?
Yes. 2 of the 3 trials are recruiting: 2 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Calcium levofolinate clinical trials?
Sichuan Baili Pharmaceutical Co., Ltd (2) and Azienda USL Reggio Emilia - IRCCS (1). The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Calcium levofolinate works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Calcium levofolinate works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Calcium levofolinate (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 9 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.